These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1376383)

  • 1. [The specific prostatic antigen: an element of diagnostic conflict?].
    Morote Robles J
    Med Clin (Barc); 1992 Apr; 98(15):598. PubMed ID: 1376383
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of prostate-specific antigen as a screening test for prostate cancer.
    N Engl J Med; 1991 Sep; 325(13):963-5. PubMed ID: 1715514
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory studies for the detection of carcinoma of the prostate.
    Brawer MK
    Urol Clin North Am; 1990 Nov; 17(4):759-68. PubMed ID: 1699341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
    Pagani F; Zambolin T; Bonora R; Panteghini M
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):85-7. PubMed ID: 1709211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour markers in monitoring the treatment of advanced prostate cancer.
    Cooper EH; Armitage TG
    Prog Clin Biol Res; 1990; 359():65-72; discussion 73-4. PubMed ID: 1704634
    [No Abstract]   [Full Text] [Related]  

  • 6. [Early detection of prostatic cancer].
    Weissbach L
    Urologe A; 1992 Jul; 31(4):193-4. PubMed ID: 1381124
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostatic specific antigen in prostate cancer.
    Wozniak-Petrofsky J
    Urol Nurs; 1992 Sep; 12(3):104-5. PubMed ID: 1382317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Occult cancer in patients with symptomatic benign prostatic hyperplasia].
    Rodríguez Duarte C; Aguillón J; Rodríguez H
    Arch Esp Urol; 1991 May; 44(4):411-4. PubMed ID: 1712190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate specific antigen: clinical use in the diagnosis and management of prostate cancer.
    Kabalin JN
    Geriatrics; 1992 Sep; 47(9):26-32. PubMed ID: 1380941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early diagnosis of prostatic cancer in France in 1989].
    Küss R
    An R Acad Nac Med (Madr); 1990; Spec No():13-8. PubMed ID: 1702942
    [No Abstract]   [Full Text] [Related]  

  • 11. [Specific prostatic antigen: usefulness in clinical practice].
    Isa Kroon WA; Sánchez de la Muela PL; Berian Polo JM
    Med Clin (Barc); 1992 Mar; 98(9):345-7. PubMed ID: 1374824
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical use of the prostate-specific antigen in patients with prostatic cancer].
    Matveev BP; Sokolov AV; Bukharkin BV; Ledian KM; Tilk AE; Makarova GV
    Urol Nefrol (Mosk); 1991; (4):8-12. PubMed ID: 1719686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
    Sakai N; Ogawa T; Ishibashi Y; Fukuoka H; Sakanishi S
    Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum prostatic acid phosphatase activity and prostate specific antigen when the prostate gland is enlarged.
    Jenkins D; Jones RT; Clarke AM
    Med Lab Sci; 1991 Apr; 48(2):161-3. PubMed ID: 1719330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [After care of prostatic cancer].
    Ebert T
    Urologe A; 1992 Jul; 31(4):196-7. PubMed ID: 1381125
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostatic diseases: tumor markers (PAP and PSA) and age at risk].
    Manna A; Trasatti L; Cifaldi L; Marchei GG; Reale MG; Marchei P
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):91. PubMed ID: 1709213
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate-specific antigen for staging prior to surgery and for early detection of recurrence after surgery.
    Lange PH
    Urol Clin North Am; 1990 Nov; 17(4):813-7. PubMed ID: 1699343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of PSA in prostatic adenocarcinoma].
    Manca GP
    Minerva Med; 1990 Apr; 81(4):261-4. PubMed ID: 1692981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Gamma-seminoprotein--a new tumour marker in prostatic cancer?
    Scheit KH
    Br J Urol; 1991 Sep; 68(3):331-2. PubMed ID: 1717099
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
    Lange PH; Brawer MK
    Urology; 1989 Jun; 33(6 Suppl):13-7. PubMed ID: 2471346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.